(VIANEWS) – SOGECLAIR (SOG.PA), MELEXIS (MELE.BR), BE SEMICONDUCTOR (BESI.AS) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| SOGECLAIR (SOG.PA) | 4.48% | 2023-03-02 07:03:54 |
| MELEXIS (MELE.BR) | 4.39% | 2023-03-02 07:16:00 |
| BE SEMICONDUCTOR (BESI.AS) | 4.02% | 2023-03-02 07:00:59 |
| BOIRON (BOI.PA) | 2.25% | 2023-03-02 07:45:30 |
Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. SOGECLAIR (SOG.PA)
4.48% Foward Dividend Yield
SOGECLAIR’s last close was €19.90, 23.46% under its 52-week high of €26.00. Intraday change was 0.5%.
Sogeclair SA provides engineering and production services to the aeronautics, space, civil and military transport in France. It operates through three divisions: Aerospace, Vehicle, and Simulation. The Aerospace division engages in the provision of engineering services in aerostructures, cabins, systems, and manufacturing engineering and tooling services; and design and manufacture of complex structural thermoplastic products, additive manufacturing, and cockpit equipment, as well as cabin furniture and mechanism. The Vehicle division is involved in the design and production of special civilian and military vehicles, as well as terrestrial drones, multi-mission platforms, and adapting vehicles. The Simulation division engages in the design and supply of turnkey simulators; and development of software simulation platforms. Sogeclair SA was incorporated in 1986 and is headquartered in Blagnac, France.
Earnings Per Share
As for profitability, SOGECLAIR has a trailing twelve months EPS of €-4.84.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.11%.
Volume
Today’s last reported volume for SOGECLAIR is 57 which is 89.91% below its average volume of 565.
More news about SOGECLAIR.
2. MELEXIS (MELE.BR)
4.39% Foward Dividend Yield
MELEXIS’s last close was €103.40, 1.99% below its 52-week high of €105.50. Intraday change was -1.55%.
Melexis NV designs, develops, tests, and markets advanced integrated semiconductor devices primarily for the automotive industry in Europe, the Middle-East, Africa, the Asia Pacific, and North and Latin America. The company provides magnetic position, latch and switch, current, inductive position, tire monitoring, temperature, optical, pressure, and speed sensor ICs. It also offers embedded motor driver, fan and pump, LED, and pre driver ICs; and LIN/CAN system basis, NFC/RFID, radio-frequency receiver and transmitter, and switch controller ICs. The company was founded in 1988 and is headquartered in Ieper, Belgium. Melexis NV is a subsidiary of Xtrion N.V.
Earnings Per Share
As for profitability, MELEXIS has a trailing twelve months EPS of €1.89.
PE Ratio
MELEXIS has a trailing twelve months price to earnings ratio of 53.75. Meaning, the purchaser of the share is investing €53.75 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 45.26%.
Sales Growth
MELEXIS’s sales growth is 22.9% for the ongoing quarter and 18.6% for the next.
Volatility
MELEXIS’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.07%, a negative 0.03%, and a positive 1.48%.
MELEXIS’s highest amplitude of average volatility was 0.97% (last week), 1.18% (last month), and 1.48% (last quarter).
Yearly Top and Bottom Value
MELEXIS’s stock is valued at €101.80 at 21:50 EST, below its 52-week high of €105.50 and way above its 52-week low of €63.05.
More news about MELEXIS.
3. BE SEMICONDUCTOR (BESI.AS)
4.02% Foward Dividend Yield
BE SEMICONDUCTOR’s last close was €73.76, 13.12% below its 52-week high of €84.90. Intraday change was -1.44%.
BE Semiconductor Industries N.V. develops, manufactures, markets, sells, and services semiconductor assembly equipment for the semiconductor and electronics industries worldwide. The company's principal products include die attach equipment, such as single chip, multi chip, multi module, flip chip, thermal compression bonding, fan out wafer level packaging, hybrid and embedded bridge die bonding, and die sorting systems; and packaging equipment, including conventional, ultra thin, and wafer level molding, as well as trim and form, and singulation systems. Its principal products also comprise plating equipment comprising tin, copper, and precious metal and solar plating systems, as well as related process chemicals; and tooling, conversion kits, spare parts, and other services. The company's principal brand names include Datacon, Esec, Fico, and Meco. It offers its products primarily to multinational chip manufacturers, assembly subcontractors, and electronics and industrial companies. The company was incorporated in 1995 and is headquartered in Duiven, the Netherlands.
Earnings Per Share
As for profitability, BE SEMICONDUCTOR has a trailing twelve months EPS of €3.21.
PE Ratio
BE SEMICONDUCTOR has a trailing twelve months price to earnings ratio of 22.65. Meaning, the purchaser of the share is investing €22.65 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 38.57%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BE SEMICONDUCTOR’s stock is considered to be oversold (<=20).
Revenue Growth
Year-on-year quarterly revenue growth declined by 19.8%, now sitting on 722.87M for the twelve trailing months.
More news about BE SEMICONDUCTOR.
4. BOIRON (BOI.PA)
2.25% Foward Dividend Yield
BOIRON’s last close was €41.60, 21.8% under its 52-week high of €53.20. Intraday change was 0.6%.
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. In addition, it provides dietary supplement; Dermoplasmine stick, baume, and mousse to treat dry lips and skin; Mag' Nuit, a formula to fall asleep; Arnitrosium for joint pain; Castor Equi Boiron ointment for treatment of cracked skin; and Storinyl, a syrup to treat colds. Further, it offers herbal medicines, such as Canephron to increase the amount of urine and to improve urinary elimination; moisturizing baby milk; and medical devices, including a range of COVID self-tests and rapid antigenic tests. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.
Earnings Per Share
As for profitability, BOIRON has a trailing twelve months EPS of €2.89.
PE Ratio
BOIRON has a trailing twelve months price to earnings ratio of 14.48. Meaning, the purchaser of the share is investing €14.48 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.87%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BOIRON’s stock is considered to be overbought (>=80).
Moving Average
BOIRON’s value is below its 50-day moving average of €45.94 and below its 200-day moving average of €44.90.
Revenue Growth
Year-on-year quarterly revenue growth grew by 35.2%, now sitting on 522.03M for the twelve trailing months.
More news about BOIRON.
